Study: Artificial intelligence screenings improve eye care access in sub-Saharan AfricaJune 14th 2022
The research from eye care nonprofit Orbis International focuses on diabetic retinopathy in Rwanda, where associated vision complications from diabetes are growing.
iSTAR Medical unveils positive results for MINIject across trio of international glaucoma trialsJune 11th 2022
According to the company, no safety concerns with corneal endothelial health reported across all 3 trials, and the device delivered consistent results up to two-year follow-up in patients across Central and South America, Asia and Europe.
Effect of drusen and atrophy in dry AMD on automated segmentation in OCT imagesMay 26th 2022
Alterations of the outer retinal layers from age-related macular degeneration (AMD) can interfere with the automated segmentation of the individual retinal layer thicknesses when using macular optical coherence tomography (OCT).
Digital patient engagement tackles the labor crisis, improves the patient experienceMay 16th 2022
For health care workers, the pandemic has led to increased burnout, concerns about workplace safety, and staffing shortages that threaten not only patient care but also the entire provider ecosystem.
OMNY Health debuts ophthalmology-centric real-world data platformMay 13th 2022
The company is partnering with leading ophthalmology practices focused on improving patient outcomes. OMNY solutions are derived from electronic health record data and provide valuable information on the evolving treatment paradigm for patients with ophthalmic disease, including difficult to obtain insights on the rationale behind treatment decisions, and the impact of social determinants of health on care delivery and outcomes.
Patricia Bath, MD, inducted into the National Inventors Hall of FameMay 5th 2022
Bath was recognized as the first Black woman physician to receive a medical patent, as well as the first woman to lead a post-graduate training program in ophthalmology. She joins four other inventors as the most recent inductees into the Hall.
Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipelineApril 29th 2022
Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.
Advances in cyclophotocoagulation: Good, better, bestApril 28th 2022
Ophthalmologists have seen a progression in cyclophotocoagulation (CPC), with each generation becoming more doctor and patient friendly. Shan C. Lin, MD, a glaucoma specialist at the Glaucoma Center of San Francisco in California, described the advances in the technology.
BioTissue continues the rollout of its corporate rebrandingApril 27th 2022
Earlier this year, BioTissue announced the corporate rebrand of its new customer facing entity, including carrying the name over to its surgical business formally known as Amniox Medical. Randy Mansfield, VP of marketing for BioTissue, shares an update at ASCRS 2022.
The glaucoma market: Novel devices, drugs drive rapid, sustained expansionApril 26th 2022
The glaucoma market seems to be in an expansion phase, as evidenced by the explosions in the number of new pharmaceutical and surgical options entering the marketplace. The introduction of new devices is possibly the single most influential factor currently driving the glaucoma market.
The offerings and limitations of digital health care in ophthalmologyApril 21st 2022
Over the past 2 years, retina specialists and their patients have learned how AI may be a tool physicians can use to monitor patients for disease progression, how telemedicine might mean more than a mere video chat between patient and clinician, and how the tools of the 21st century were closer to real-world practice than anticipated.